Home › Biliary Tract Cancer › Colorado › Denver
Biliary Tract Cancer clinical trials in Denver, CO
3 studies for Biliary Tract Cancer are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
RecruitingPhase 1/2
- Sarah Cannon Research Institute (SCRI), Denver
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RecruitingPhase 1/2
- Avenzo Therapeutics Recruiting Site, Denver
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
- Sarah Cannon Research Institute, Denver
Biliary Tract Cancer trials in other cities
- Houston, TX18 studies
- Boston, MA11 studies
- Los Angeles, CA11 studies
- New York City, NY10 studies
- Nashville, TN9 studies
- San Antonio, TX8 studies
- Baltimore, MD8 studies
- Washington, DC7 studies
- Arlington, VA7 studies
- Pittsburgh, PA7 studies
- Columbus, OH6 studies
- Madison, WI6 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer28 studies
- Non-Small Cell Lung Cancer27 studies
- Multiple Myeloma26 studies
- Colorectal Cancer23 studies
- Cancer (all types)19 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Ovarian Cancer16 studies
- Endometrial Cancer16 studies
- Lung Cancer16 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.